BOON FAWES CAPSULE
BOON FAWES CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL22116112TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- TOPHERBS ENTERPRISE
- Manufacturer
- SG GLOBAL BIOTECH SDN. BHD.
- Registration date
- 2022-11-22
- Published validity end
- 2027-11-22
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Cyperus rotundus L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes et allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Atractylodes macrocephala | Atractylodes macrocephala[14 mg,400 mg] | Not identified |
| Poria cocos | Poria cocos[14 mg,400 mg] | Not identified |
| Santalum album | Santalum album[14 mg,400 mg] | Not identified |
| Eugenia caryophyllata | Eugenia caryophyllata[14 mg,400 mg] | Not identified |
| Alpinia officinarum | Alpinia officinarum[41 mg,400 mg] | Not identified |
| Citrus reticulata | Citrus reticulata[14 mg,400 mg] | Not identified |
| Amomum villosum | Amomum villosum[41 mg,400 mg] | Not identified |
| Citrus aurantium | Citrus aurantium[14 mg,400 mg] | Not identified |
| Agastache rugosa | Agastache rugosa[14 mg,400 mg] | Not identified |
| Aucklandia lappa | Aucklandia lappa[41 mg,400 mg] | Not identified |
| Cyperus rotundus | Cyperus rotundus[41 mg,400 mg] | Not identified |
| Glycyrrhiza uralensis | Glycyrrhiza uralensis[14 mg,400 mg] | Not identified |
| Amomum kravanh | Amomum kravanh[41 mg,400 mg] | Not identified |
| Atractylodes lancea | Atractylodes lancea[14 mg,400 mg] | Not identified |
| Taraxacum mongolicum | Taraxacum mongolicum[41 mg,400 mg] | Not identified |
| Curcuma aromatica | Curcuma aromatica[28 mg,400 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Atractylodes macrocephala[14 mg,400 mg],Poria cocos[14 mg,400 mg],Santalum album[14 mg,400 mg],Eugenia caryophyllata[14 mg,400 mg],Alpinia officinarum[41 mg,400 mg],Citrus reticulata[14 mg,400 mg],Amomum villosum[41 mg,400 mg],Citrus aurantium[14 mg,400 mg],Agastache rugosa[14 mg,400 mg],Aucklandia lappa[41 mg,400 mg],Cyperus rotundus[41 mg,400 mg],Glycyrrhiza uralensis[14 mg,400 mg],Amomum kravanh[41 mg,400 mg],Atractylodes lancea[14 mg,400 mg],Taraxacum mongolicum[41 mg,400 mg],Curcuma aromatica[28 mg,400 mg]
- Valid until
- 2027-11-22
- Registration date
- 2022-11-22
- Published description
- NATURAL PRODUCT
- Licence holder
- TOPHERBS ENTERPRISE
- Producer
- SG GLOBAL BIOTECH SDN. BHD.
- Published name
- BOON FAWES CAPSULE
- Published reference
- 202205257845T
- Registration number
- MAL22116112TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL22116112TC
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.